开能健康 reported revenue of ¥0.92B for the period ended 2026-06-30, +1.5% year on year. Net income was ¥0.07B, a 7.1% net margin on a 41.6% gross margin. The largest revenue line is 终端业务及服务 at 62% of the total. Free cash flow for the period was ¥0.08B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.92B | +1.5% |
| Gross profit | ¥0.38B | — |
| Operating income | ¥0.09B | — |
| Net income | ¥0.07B | -22.3% |
| Gross margin | 41.6% | Net margin 7.1% |
| Revenue Q/Q | +20.6% | — |
| Segment | Revenue | Share |
|---|---|---|
| 终端业务及服务 | ¥0.57B | 61.5% |
| 智能制造及核心部件 | ¥0.33B | 35.6% |
| 实验动物服务、细胞制备及其他业务 | ¥0.02B | 1.8% |
| 其他生态产品及业务 | ¥0.01B | 1.1% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.54B | 58.4% |
| R&D | ¥0.04B | 4.1% |
| SG&A | ¥0.21B | 23.1% |
| Tax & other | ¥0.02B | 2.2% |
| Item | Amount |
|---|---|
| Total assets | ¥3.53B |
| Total liabilities | ¥2.14B |
| Shareholders' equity | ¥1.39B |
| Equity / assets | 39.3% |
| Operating cash flow | ¥0.13B |
| Capital expenditure | ¥0.04B |
| Free cash flow | ¥0.08B |
| Cash conversion (OCF / net income) | 240% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
梅安森 ・ 三丰智能 ・ 汽轮科技 ・ 华昌达 ・ 和晶科技 ・ 金明精机 ・ 温州宏丰 ・ 苏交科 ・ 国瓷材料 ・ 安科瑞 ・ 飞利信 ・ 朗玛信息
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies